| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Institut National de la Santé et de la Recherche Médicale, Unité 448, Faculté de Médecine de Créteil, Créteil, France; and
Laboratoire d’Immunologie Cellulaire, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7627, Centre Hospitalier Pitié-Salpêtrière, Paris, France
CD100 is the first semaphorin described in lymphoid tissues, where it has been shown to be associated with a serine kinase activity. Semaphorins are molecules involved in axon pathfinding during nerve development and act as repellent guidance cues. In the nervous system semaphorins exist as either membrane-bound or secreted forms. We report here a spontaneous processing of membrane CD100, suggesting that it is also produced as a diffusable semaphorin from lymphoid cells. Monomeric and homodimeric forms of CD100 are expressed by T lymphocytes and CD100-transfected fibroblasts. We demonstrate that CD100 is released through a proteolytic process blocked by metalloprotease inhibitors. In T cells, only soluble CD100 dimers are produced, suggesting that CD100 dimerization is required for proteolysis. In agreement, we observe that increasing membrane dimers strongly favors shedding of the molecule. By expressing a CD100 molecule mutated at cysteine 674 into a COS cell system, we additionally demonstrate that this particular residue in the extracellular domain of the molecule is required for dimerization. Finally, we show that staurosporine, a serine kinase inhibitor, enhances the membrane cleavage of CD100. Together these results demonstrate that membrane CD100 is cleaved by a metalloprotease-dependent process, which is probably regulated by phosphorylation. Mainly, these findings shed light on a possible function for the semaphorin region of CD100 as a long range guidance cue in the immune system.
This article has been cited by other articles:
|
|
 |
|
  J. R. Sierra, S. Corso, L. Caione, V. Cepero, P. Conrotto, A. Cignetti, W. Piacibello, A. Kumanogoh, H. Kikutani, P. M. Comoglio, et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages J. Exp. Med., July 7, 2008; 205(7): 1673 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Basile, K. Holmbeck, T. H. Bugge, and J. S. Gutkind MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D J. Biol. Chem., March 2, 2007; 282(9): 6899 - 6905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhu, W. Bergmeier, J. Wu, H. Jiang, T. J. Stalker, M. Cieslak, R. Fan, L. Boumsell, A. Kumanogoh, H. Kikutani, et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury PNAS, January 30, 2007; 104(5): 1621 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Basile, R. M. Castilho, V. P. Williams, and J. S. Gutkind Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis PNAS, June 13, 2006; 103(24): 9017 - 9022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gautier, B. de Saint-Vis, B. Senechal, J.-J. Pin, E. E.M. Bates, C. Caux, F. Geissmann, and P. Garrone The Class 6 Semaphorin SEMA6A Is Induced by Interferon-{gamma} and Defines an Activation Status of Langerhans Cells Observed in Pathological Situations Am. J. Pathol., February 1, 2006; 168(2): 453 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Conrotto, D. Valdembri, S. Corso, G. Serini, L. Tamagnone, P. M. Comoglio, F. Bussolino, and S. Giordano Sema4D induces angiogenesis through Met recruitment by Plexin B1 Blood, June 1, 2005; 105(11): 4321 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Chabbert-de Ponnat, A. Marie-Cardine, R. J. Pasterkamp, V. Schiavon, L. Tamagnone, N. Thomasset, A. Bensussan, and L. Boumsell Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively Int. Immunol., April 1, 2005; 17(4): 439 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Giraudon, P. Vincent, C. Vuaillat, O. Verlaeten, L. Cartier, A. Marie-Cardine, M. Mutin, A. Bensussan, M.-F. Belin, and L. Boumsell Semaphorin CD100 from Activated T Lymphocytes Induces Process Extension Collapse in Oligodendrocytes and Death of Immature Neural Cells J. Immunol., January 15, 2004; 172(2): 1246 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kumanogoh and H. Kikutani Immune semaphorins: a new area of semaphorin research J. Cell Sci., September 1, 2003; 116(17): 3463 - 3470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Rao, K. Wong, M. Ward, C. Jurgensen, and J. Y. Wu Neuronal migration and molecular conservation with leukocyte chemotaxis Genes & Dev., December 1, 2002; 16(23): 2973 - 2984. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bismuth and L. Boumsell Controlling the Immune System Through Semaphorins Sci. Signal., April 16, 2002; 2002(128): re4 - re4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Watanabe, A. Kumanogoh, W. Shi, K. Suzuki, S. Yamada, M. Okabe, K. Yoshida, and H. Kikutani Enhanced Immune Responses in Transgenic Mice Expressing a Truncated Form of the Lymphocyte Semaphorin CD100 J. Immunol., October 15, 2001; 167(8): 4321 - 4328. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
